|
|||||
|
|
Preliminary clinical trials and clinical pharmacologic studies with 5-(3,3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196) given orally |
|
| Authors: | C L Vogel V T DeVita C Denham H T Foley R B Field P P Carbone |
| Abstract: | |
| Keywords: | |